Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT00698893
Eligibility Criteria:
Inclusion Criteria:
* Between 18 and 40 years of age
* Seropositive for antibodies against HSV
* Female volunteers must have been using contraceptives for at least 2 months before the entry and should avoid becoming pregnant for the duration of this study.
* Good physical condition as established by physical examination and history taking at the time of entry
Exclusion Criteria:
* Any abnormal laboratory value among the tests performed at screening.
* History of persistent hepatic, renal, cardiac or respiratory diseases
* Clinical signs of acute illness at the time of entry into the study.
* Previous history of asthma or hypersensitivity to drugs.
* Seropositive for antibodies against the human immunodeficiency virus
* Pregnancy and lactation.
* Treatment with corticosteroids or immunomodulating drugs.
* Simultaneous participation in another clinical trial.
* Administration of any other vaccine or immunoglobulins during the study period
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT00698893
Study Brief:
Protocol Section:
NCT00698893